In the heterozygous form of familial hypercholesterolemia (FH), blood concentrations of low-
density lipoprotein cholesterol (LDL-C) are elevated two to three times above the normal …

Objective—Functional and morphological changes of the arterial wall already present in
young children with heterozygous familial hypercholesterolemia (HeFH) suggest that …

Familial hypercholesterolemia in children and adolescents : Current Opinion in Lipidology
Familial hypercholesterolemia in children and adolescents : Current Opinion in Lipidology Log …

Purpose Statins are the mainstay of treatment for patients with familial
hypercholesterolaemia (FH). However, their efficacy and safety in children and adolescents …

AIMS: To assess efficacy and safety of HMG-CoA reductase inhibitor (statin) treatment in
children and adolescents with heterozygous familial hypercholesterolaemia. METHODS …

Heterozygous familial hypercholesterolemia (heFH) affects 1 in 500 individuals. Evidence
supports the low-density lipoprotein (LDL)-lowering effect of statins for adults with heFH …

Abstract Purpose of Review Familial hypercholesterolemia (FH), a common inherited
disorder of LDL-C metabolism that predisposes to premature cardiovascular disease, is …

Background For children with familial hypercholesterolemia (FH), UK guidelines recommend
consideration of statin therapy by age 10 years and dietary and lifestyle advice to maintain …

Abstract Purpose of Review Statins are first-line therapy for lowering low-density lipoprotein
(LDL) cholesterol in familial hypercholesterolemia (FH), particularly in heterozygous …

Background Early identification of children with familial hypercholesterolemia (FH) makes it
possible to start lipid-lowering therapy at a young age in order to prevent cardiovascular …